Global Transplantation of Multipotent Hematopoietic Stem Cells Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Transplantation of Multipotent Hematopoietic Stem Cells Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Over 50 years of studies in the field of blood-forming stem cells i.e. hematopoietic stem cells (HSC), researchers have developed significant understanding to use HSCs as a therapy. At present, no type of stem cell, adult, embryonic or fetal has attained such sufficient status. Hematopoietic stem cell transplantation (HSCT) is now routinely used for treating patients with malignant and non-malignant disorders of blood and the immune system. Currently, researchers have observed that through animal studies HSCs have the ability to form other cells such as blood vessels, muscles, and bone.
Transplantation of Multipotent Hematopoietic Stem Cells report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Transplantation of Multipotent Hematopoietic Stem Cells market is projected to reach US$ 2627.2 million in 2033, increasing from US$ 1348 million in 2022, with the CAGR of 10.0% during the period of 2023 to 2033. Demand from Leukemia and Lymphoproliferative Disorders are the major drivers for the industry.
The Transplantation of Hematopoietic Stem Cells market is primarily driven by its potential to provide curative treatments for various hematological disorders, including leukemia, lymphoma, and certain genetic diseases. Hematopoietic stem cell transplantation (HSCT) involves replacing damaged or malfunctioning bone marrow with healthy stem cells to restore normal blood cell production. The increasing prevalence of hematological diseases, coupled with advancements in transplantation techniques, contributes to market growth. Moreover, the demonstrated benefits of HSCT in achieving long-term remission, improving overall survival rates, and offering a potential cure for patients with limited treatment options further propel adoption. However, challenges include finding suitable donors, addressing potential graft-versus-host disease and other complications, and managing post-transplant care. Navigating patient-donor matching, ensuring graft compatibility, and providing comprehensive patient support are ongoing concerns. The market's success relies on continuous research in transplantation science, collaborations between medical institutions and stem cell banks, and comprehensive education on the benefits and potential challenges of hematopoietic stem cell transplantation while addressing the evolving challenges associated with donor availability and patient outcomes.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Transplantation of Multipotent Hematopoietic Stem Cells market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
CBR Systems
China Cord Blood Corporation
ViaCord
Thermo Fisher Scientific
STEMCELL Technologies
Vcanbio
Merck Millipore
Lonza Group
CellGenix Technologie Transfer
ThermoGenesis
Segment by Type
Stem Cells Storage
Stem Cells Consumables
Leukemia
Lymphoproliferative Disorders
Solid Tumors
Non-Malignant Disorders
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Transplantation of Multipotent Hematopoietic Stem Cells market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Transplantation of Multipotent Hematopoietic Stem Cells introduction, etc. Transplantation of Multipotent Hematopoietic Stem Cells Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Transplantation of Multipotent Hematopoietic Stem Cells market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Transplantation of Multipotent Hematopoietic Stem Cells report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Transplantation of Multipotent Hematopoietic Stem Cells market is projected to reach US$ 2627.2 million in 2033, increasing from US$ 1348 million in 2022, with the CAGR of 10.0% during the period of 2023 to 2033. Demand from Leukemia and Lymphoproliferative Disorders are the major drivers for the industry.
The Transplantation of Hematopoietic Stem Cells market is primarily driven by its potential to provide curative treatments for various hematological disorders, including leukemia, lymphoma, and certain genetic diseases. Hematopoietic stem cell transplantation (HSCT) involves replacing damaged or malfunctioning bone marrow with healthy stem cells to restore normal blood cell production. The increasing prevalence of hematological diseases, coupled with advancements in transplantation techniques, contributes to market growth. Moreover, the demonstrated benefits of HSCT in achieving long-term remission, improving overall survival rates, and offering a potential cure for patients with limited treatment options further propel adoption. However, challenges include finding suitable donors, addressing potential graft-versus-host disease and other complications, and managing post-transplant care. Navigating patient-donor matching, ensuring graft compatibility, and providing comprehensive patient support are ongoing concerns. The market's success relies on continuous research in transplantation science, collaborations between medical institutions and stem cell banks, and comprehensive education on the benefits and potential challenges of hematopoietic stem cell transplantation while addressing the evolving challenges associated with donor availability and patient outcomes.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Transplantation of Multipotent Hematopoietic Stem Cells market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
CBR Systems
China Cord Blood Corporation
ViaCord
Thermo Fisher Scientific
STEMCELL Technologies
Vcanbio
Merck Millipore
Lonza Group
CellGenix Technologie Transfer
ThermoGenesis
Segment by Type
Stem Cells Storage
Stem Cells Consumables
Segment by Application
Leukemia
Lymphoproliferative Disorders
Solid Tumors
Non-Malignant Disorders
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Transplantation of Multipotent Hematopoietic Stem Cells market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Transplantation of Multipotent Hematopoietic Stem Cells introduction, etc. Transplantation of Multipotent Hematopoietic Stem Cells Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Transplantation of Multipotent Hematopoietic Stem Cells market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices